Is My MPN Treatment Working?

https://vimeo.com/474777536 During myeloproliferative neoplasm (MPN) treatment, specific blood tests and diagnostic measurements help to gauge a patient’s treatment response. Dr. Brady Stein details the criteria he assesses in monitoring the…

MPN Treatment Choices: Where Do Clinical Trials Fit In?

https://vimeo.com/474723322 When considering MPN treatment approaches, clinical trials are a viable option for care. Dr. Brady Stein discusses clinical trials and factors to keep in mind when considering participation. Dr….

What Factors Guide Treatment Choices for ET, PV & MF?

https://vimeo.com/474723548 When making a myeloproliferative neoplasm (MPN) treatment decision, several factors come into play. Dr. Brady Stein explains what criteria he considers to determine the optimal approach for a patient’s…

How Do Test Results Inform MPN Prognosis & Treatment?

https://vimeo.com/474777785 Dr. Brady Stein explains the diagnostic tests and genetic mutations that are assessed to determine prognosis and what MPN treatment may work best. Dr. Brady Stein is a hematologist…

Tools to Help You Learn More About MPN Clinical Trials

https://vimeo.com/472643427 Research is quickly evolving for essential thrombocythemia (ET), polycythemia vera (PV), and myelofibrosis (MF), all due to clinical trials. Dr. Laura Michaelis reviews tools for learning about clinical trials…

What Are the Treatment Options for Myelofibrosis?

https://vimeo.com/472643614 When choosing a treatment for myelofibrosis (MF), where do you start? Dr. Laura Michaelis reviews the available options for MF therapy, including a discussion of stem cell transplant.  Dr….

Monitoring MPNs: When is it Time to Switch Therapies?

https://vimeo.com/449694287 MPN expert, Dr. Srdan Verstovsek reviews factors that may indicate a treatment change for patients with essential thrombocythemia (ET), polycythemia vera (PV) and myelofibrosis (MF). Dr. Srdan Verstovsek is…

Which MPN Treatment is Right for You? Factors to Consider

https://vimeo.com/449694000 Dr. Srdan Verstovsek, discusses how multiple factors, including diagnosis and symptom burden, determine which MPN treatment path may help improve a patient’s outcome. Dr. Srdan Verstovsek is Chief of…

MPN Treatment: Why Testing for Mutations Matters

https://vimeo.com/449693685 Testing for mutations can influence treatment options available to patients with MPNs and provide a more in-depth understanding into their essential thrombocythemia (ET), polycythemia vera (PV) or myelofibrosis (MF)…

Share On:

Facebook
Twitter
LinkedIn